Union Budget 2022-23: Digitization to drive the healthcare sector
As India celebrates ‘Azadi ka Amrit Mohatsav’, the union budget created a blueprint for India’s sustainable development and laid a […]
Say something
As India celebrates ‘Azadi ka Amrit Mohatsav’, the union budget created a blueprint for India’s sustainable development and laid a […]
The Prime Minister recently launched the Pradhan MantriAtmanirbhar Swasth Bharat Yojana (PMASBY), worth ₹64,180 crore, to strengthen the health care […]
Suresh Vazirani, Founder Chairman & Managing Director, TransasiaErba Group, in his keynote address at the virtual second edition of Elets […]
Transasia Bio-Medicals Ltd, India’s largest in-vitro diagnostic (IVD) company with a globally recognised ERBA brand, has been recognised as the […]
Suresh Vazirani-Chairman & Managing Director, Transasia Bio-Medicals Ltd, speaks about the changes of the diagnostic industry. He feels that quality […]
Transasia Bio-Medicals Limited has launched Sysmex XP “ 100, a new automated 3 part differential hematology analyzer. This next generation […]
SURESH VAZIRANI Chairman & Managing director COMPANY PROFILE: TRANSASIA BIO-MEDICALS LTD Corporate Office Transasia Bio Medical ltd, Transasia House, 8 […]
ERBA Diagnostics Mannheim, GmbH (Erba), a 100 percent subsidiary of Transasia Bio-Medicals Ltd, (Transasia) – India
Transasia Bio- Medicals Ltd, one of the leading players in the Clinical Diagnostics Segment of the Indian healthcare sector through its fully owned German subsidiary, Erba Diagnostics Mannheim GmbH has acquired a majority stake in US based company IVAX Diagnostics, Inc.
The award was presented to Mr Suresh Vazirani, CMD, Transasia Bio-Medicals Ltd. by Hon
[This article was published in the November 2009 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
Transasia Bio-Medicals Ltd. is the leader in the clinical diagnostics segment of the Indian healthcare sector, providing total solutions for clinical diagnosis.